Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.
Yu Zhang, Sijian Yu, Guopan Yu, Yu Wang, Ruoyang Shao, Xin Du, Na Xu, Dongjun Lin, Weihua Zhao, Xiong Zhang, Jie Xiao, Zhiqiang Sun, Lan Deng, Xinquan Liang, Ziwen Guo, Hua Jin, Qifa Liu, Li Xuan, Xuejie Jiang, Ren Lin, Qiong Liu, Zhiping Fan, Fen Huang, Pengcheng Shi, Min Dai, Hongyu Zhang
Journal of internal medicine 2024;295(2):216-228